During Wednesday’s Current trade, Shares of Starwood Hotels & Resorts Worldwide Inc (NYSE:HOT), lost -1.73% to $75.12.
Westin Hotels & Resorts, part of Starwood Hotels & Resorts (HOT), declared the opening of its latest Austin hotel, The Westin Austin Downtown, located in the heart of the city at the corner of San Jacinto Boulevard and Fifth Street. A joint venture among White Lodging Services Corporation, the Harry Whittington family and REI Real Estate Services, LLC., the 19-story hotel, which draws design inspiration from the local music scene, is Westin’s second Austin property, and one of five new openings in North America this year.
The Westin Austin Downtown used HKS Architects, Inc. and was designed by Simeone Deary. Upon entering the lobby, guests are transported to a modern-day oasis where they are met with a 12-foot-tall custom-made art piece comprised of charred wood blocks that come together to form the body of a guitar. Incorporating natural design elements, the lobby ceiling and vertical garden mimic the cutouts of a Dobro guitar, while the ballroom floors allude to prints often found on guitar straps. In keeping with the Austin music theme, the hotel will regularly host local musicians in the lounge area.
Starwood Hotels & Resorts Worldwide, Inc., together with its auxiliaries, operates as a hotel and leisure company worldwide. The company owns, operates, and franchises luxury and upscale full-service hotels, resorts, residences, retreats, select-service hotels, and extended stay hotels under the St. Regis, The Luxury Collection, W, Westin, Le Méridien, Sheraton, Four Points, Aloft, and Element brand names.
Shares of EnteroMedics Inc (NASDAQ:ETRM), inclined 2.13% to $0.211, during its current trading session.
EnteroMedics Inc. (ETRM), a developer and manufacturer of devices that use neuroblocking technology to treat obesity, metabolic diseases, and other gastrointestinal disorders, recently declared the closing of its formerly declared public offering of 32,000,000 units (the “Offering”) generating net proceeds of about US$14.7 million, with each unit compriseing of one share of common stock and one Series A warrant to purchase one share of common stock at a purchase price of $0.50 per unit. Investors whose purchase of units in the offering would result in them beneficially owning more than the initial beneficial ownership limitation to be comprised of in the warrants following the consummation of the offering will have the opportunity to acquire units with Series C pre-funded warrants substituted for any common stock they would have otherwise attained over the initial beneficial ownership limitation, paying the same price of $0.50 per unit. The Series A warrants will be exercisable right away and will expire 42 months after their date of issuance at an exercise price of $0.60 per share. The pre-funded Series C warrants will be exercisable right away and will expire five years following issuance.
Canaccord Genuity acted as sole book-running manager and Craig-Hallum Capital Group acted as co-manager for the offering. Northland Securities and Roth Capital Partners served as financial advisors to the Company in connection with this transaction.
EnteroMedics Inc., a medical device company, focuses on the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases, and other gastrointestinal disorders. The company’s proprietary neuroblocking technology is designed to intermittently block the vagus nerve using electrical impulses. It develops the Maestro Rechargeable System, which is used to limit the expansion of the stomach, control hunger sensations between meals, reduce the frequency and intensity of stomach contractions, and produce a feeling of early and prolonged fullness.
Ubiquiti Netoperates Inc (NASDAQ:UBNT), during its Wednesday’s current trading session decreased -1.06% to $32.13.
Ubiquiti Netoperates, Inc. (UBNT) declared results for the fourth fiscal quarter of 2015, ended June 30, 2015.
Fourth Quarter Financial Summary
- Revenues of $145.3 million
- GAAP gross profit of $66.1 million and non-GAAP gross profit of $66.3 million
- GAAP net income of $4.5 million and non-GAAP net income of $44.1 million
- GAAP diluted EPS of $0.05 and non-GAAP diluted EPS of $0.50
Recent Financial Highlights
- Enterprise Technology revenues raised over 26% year-over-year, fueled by UniFi(R)access points and other industry-leading products targeting the Enterprise market
- Initiated a new stock repurchase program, authorizing the Company to repurchase up to $100 million of its common stock as revealed in the Form 8-K filed on August 6, 2015
- Shipped in volume our new Enterprise products, counting UniFi Video products, the UniFi Switch and our newly released EdgeRouterTMX and EdgeRouterTM X SFP
Ubiquiti Netoperates, Inc., together with its auxiliaries, provides various networking products and solutions for service providers and enterprises in the United States and internationally. The company’s service provider product platforms provide carrier-class network infrastructure for fixed wireless broadband, wireless backhaul systems, and routing; and enterprise product platforms provide wireless LAN infrastructure, video surveillance products, and machine-to-machine communication components.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
